Pharmaids Pharmaceuticals Ltd

NSE: PHARMAID · BSE: 524572 · Pharmaceuticals & Biotechnology · 14 announcements

Share price: ₹30.89
Market cap: ₹108.9 Cr
Revenue (annual): ₹27.88 Cr
Net profit (annual): ₹-11.72 Cr
P/E (TTM): -23.9×Sector 47.3×
Promoter holding: 32.99%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 3 Board Meeting Date 2 Annual General Meeting 2 Promoter Buying (Off-Market) 1 Management Change 1 Legal & Regulatory 1 Debt & Borrowing 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

12 Aug 2026 19:33 IST BSE

Financial Results

Pharmaids Pharmaceuticals Q1 FY27 Results: Net Profit ₹1.9 Cr, Down 64.2% YoY

Pharmaids Pharmaceuticals Ltd reported revenue from operations of ₹4.1 Cr (-38.8% YoY) and net profit of ₹1.9 Cr (-64.2% YoY) for Q1 FY27.

Key figure: Net profit ₹1.9 Cr · -64.2% YoY

Open full results → Read the filing ↗

29 May 2026 19:21 IST BSE

Financial Results

Pharmaids Pharmaceuticals Q4 FY26 Results: Net Loss of ₹1.1 Cr, Loss Narrows

Pharmaids Pharmaceuticals Ltd reported revenue from operations of ₹7.2 Cr (+50.0% YoY) and a net loss of ₹1.1 Cr for Q4 FY26.

Key figure: Net loss ₹1.1 Cr

Open full results → Read the filing ↗

29 May 2026 19:19 IST BSE

Financial Results

Pharmaids Pharmaceuticals Financial Results

Pharmaids Pharmaceuticals reported audited FY26 results and approved a ₹0.75 Crore corporate guarantee for its subsidiary. Performance details and subsidiary support reflect ongoing operational strategy.

Value: ₹0.75 Cr

Read the filing ↗